Global High Content Screening Market is expected to grow from US$ 1,321.9 Mn in 2017 to US$ 2,039.9 Mn by 2026 End

0
45

Persistence Market Research (PMR) delivers the key insights on the global high content screening market in its upcoming outlook titled, “High Content Screening Market:  Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2026”. In terms of value, the global high content screening is projected to register a healthy CAGR of 5.0 % during the forecast period due to various factors, regarding which PMR offers vital insights in detail. Increasing demand for technological advanced products is expected bolster the growth of the global high content screening market over the forecast period.

The global high content screening market is segmented on the basis of product type, applications, industry and regions. On the basis of product type, the high content screening market is segmented into Cell Imaging & Analysis, Consumables, Software, and Services. The HCS instruments include the High end, middle end and low end screening instruments. The instruments which fall under high content screening are combined with digital microscopes with digital high resolution imaging and software. The instrument provides fluorescence imaging, bright field imaging modes and live cell imaging. Also the software reconstructs the images into data format with temperature control. Cell imaging and analysis is used to measure a wide variety of cells and whole organisms in for the analysis such as stem cells, plant tissues, and cancer cells.  Flow cytometers are devices used for analyzing the expressions of the cells surfaces, size and the volume of the cell, amount of cell components present such as total DNA and synthesized DNA, transient signaling events in the live cells. Also florescence intensity is measured by the flow cytometers by labeling the antibodies with florescent dyes for detecting proteins or ligands that bind to specific cell associated molecules. The cells are observed for RNA interference, mutations, movement of the protein molecules. The screens and devices used for imaging and analysis provides insights of the biological processes. High screening method involves the monitoring of the cells and the phenotypes, the consumables include the micro plates, the reagents and the assay kits which play a supporting role in the high content screening. These are used for high resolution microscopy for an enhanced visualization of the 3-D cell cultures, the coating in the plates enhances the cell attachments and adherence. With the technological advancements, research and development and monitoring of new drugs and cells the devices for high content screening market is gaining attraction.

On the basis of Industry, the global high content market is segmented into Pharmaceutical & Healthcare, Biotechnology, Educational Institutions, Independent CRO, Government Organizations, and others which include academic research centers. Use of high content screening equipment enables companies to extract highly informative information, which also assists pharmaceuticals and biotechnological companies to perform cell analysis. Benefits of high content screening, resulting in improved toxicity study results, has led to increased adoption of this technology by pharmaceutical companies. This has enabled researchers to investigate live cells coupled with compounds, thus offering high-throughput screening output. The educational institutions segment is expected to witness significant growth during the forecast period due to extensive research.

This report covers the trends driving the growth of each segment in the high content screening market  and offers analysis and insights of the devices used for the analysis and imaging of the cells and its validations which are offered in all the regions across the globe. The growing awareness regarding new products with the help of social media platforms is expected to fuel the growth of the market for high content screening market. The demand for high content screening has increased due to the increasing patient pool suffering from diseases.

Request For  Report Sample@ https://www.persistencemarketresearch.com/samples/12931

The growth is expected to be prominent in the cell imaging and analysis segment due to its advancement and live imaging features which allows the scientists to observe mutations and biological changes. Further, the increasing efforts from manufacturers to introduce novel product line and extensive focus on product marketing and distribution across Asia and Europe regions are the factors expected to create lucrative growth opportunities in the market.

Examples of some of the key players operating in the global high content screening market are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation and Sysmex Corporation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here